HK1135185A1 - 利用后葉激素運載蛋白製備對心功能不全進行診斷和危險分層的試劑盒 - Google Patents

利用后葉激素運載蛋白製備對心功能不全進行診斷和危險分層的試劑盒

Info

Publication number
HK1135185A1
HK1135185A1 HK10101641.9A HK10101641A HK1135185A1 HK 1135185 A1 HK1135185 A1 HK 1135185A1 HK 10101641 A HK10101641 A HK 10101641A HK 1135185 A1 HK1135185 A1 HK 1135185A1
Authority
HK
Hong Kong
Prior art keywords
neurophysin
diagnosis
kit
cardiac insufficiency
risk stratification
Prior art date
Application number
HK10101641.9A
Other languages
English (en)
Inventor
‧貝格曼
‧施特魯克
Original Assignee
布拉姆斯有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 布拉姆斯有限公司 filed Critical 布拉姆斯有限公司
Publication of HK1135185A1 publication Critical patent/HK1135185A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK10101641.9A 2006-12-08 2010-02-12 利用后葉激素運載蛋白製備對心功能不全進行診斷和危險分層的試劑盒 HK1135185A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006058266A DE102006058266A1 (de) 2006-12-08 2006-12-08 Diagnose und Risikostratifizierung von Herzinsuffizienz mittels Neurophysin
PCT/DE2007/002215 WO2008067806A2 (de) 2006-12-08 2007-12-10 Diagnose und risikostratifizierung von herzinsuffizienz mittels neurophysin

Publications (1)

Publication Number Publication Date
HK1135185A1 true HK1135185A1 (zh) 2010-05-28

Family

ID=39363234

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10101641.9A HK1135185A1 (zh) 2006-12-08 2010-02-12 利用后葉激素運載蛋白製備對心功能不全進行診斷和危險分層的試劑盒

Country Status (7)

Country Link
US (1) US20100093012A1 (zh)
EP (1) EP2100145B1 (zh)
JP (2) JP5388858B2 (zh)
CN (1) CN101583874B (zh)
DE (1) DE102006058266A1 (zh)
HK (1) HK1135185A1 (zh)
WO (1) WO2008067806A2 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2084543T3 (en) * 2006-10-26 2018-01-22 Brahms Gmbh Risk stratification of acute coronary syndrome using fragments / sub-peptides of provasopressin, especially copeptin or neurophysin II
EP2356452B1 (en) * 2008-10-31 2019-04-24 B.R.A.H.M.S GmbH Methods and assays for classifying foodstuff and/or beverage and/or diet and/or nutrition regimen and/or medicament in view of an effect on the cardiovascular system
WO2011083145A1 (en) * 2010-01-08 2011-07-14 Cavadis B.V. Determination of exosomel biomarkers for predicting cardiovascular events
EP2533052A1 (en) * 2011-06-07 2012-12-12 B.R.A.H.M.S GmbH Diagnostic use of proSomatostatin
JP5802614B2 (ja) * 2012-06-15 2015-10-28 富士フイルム株式会社 臨床情報表示装置および臨床情報表示装置の動作方法並びに臨床情報表示プログラム
JP5802615B2 (ja) * 2012-06-18 2015-10-28 富士フイルム株式会社 臨床情報表示装置および臨床情報表示装置の動作方法並びに臨床情報表示プログラム
US10415094B2 (en) 2016-10-06 2019-09-17 HelicalHelp LLC Risk stratification method for a patient having a polymorphism

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9305142D0 (en) * 1993-03-12 1993-04-28 Medinnova Sf Method
IL161446A0 (en) * 2001-11-26 2004-09-27 Daiichi Suntory Pharma Co Ltd Medicinal compositions for nasal absorption
MXPA03004105A (es) * 2002-05-14 2004-10-15 Hoffmann La Roche Elaboracion de una prognosis en casos de enfermedad cardiaca usando una combinacion de marcadores.
WO2004006860A2 (en) * 2002-07-16 2004-01-22 Woomera Therapeutics, Inc. Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells
EP1530047A1 (en) * 2003-11-07 2005-05-11 Roche Diagnostics GmbH Proximal markers of arterial thrombosis and inflammation for risk stratification of coronary heart disease
EP1628136A1 (en) * 2004-08-19 2006-02-22 B.R.A.H.M.S. Aktiengesellschaft Method of diagnosis of disease using copeptin
EP2924440A3 (en) * 2006-06-07 2016-03-09 Health Diagnostic Laboratory, Inc. Markers associated with arteriovascular events and methods of use thereof
DK2084543T3 (en) * 2006-10-26 2018-01-22 Brahms Gmbh Risk stratification of acute coronary syndrome using fragments / sub-peptides of provasopressin, especially copeptin or neurophysin II

Also Published As

Publication number Publication date
JP5388858B2 (ja) 2014-01-15
JP2010511877A (ja) 2010-04-15
EP2100145A2 (de) 2009-09-16
US20100093012A1 (en) 2010-04-15
EP2100145B1 (de) 2018-02-28
CN101583874A (zh) 2009-11-18
CN101583874B (zh) 2014-06-25
DE102006058266A1 (de) 2008-06-12
WO2008067806A2 (de) 2008-06-12
WO2008067806A3 (de) 2008-09-25
JP2013210385A (ja) 2013-10-10

Similar Documents

Publication Publication Date Title
HK1245147A1 (zh) 激活素-actrii的拮抗劑及在提高紅細胞水平中的用途
HK1206419A1 (zh) 預測主要不利心臟事件的風險
HK1135185A1 (zh) 利用后葉激素運載蛋白製備對心功能不全進行診斷和危險分層的試劑盒
EP2155065A4 (en) PROCESS FOR THE IMAGE DISPLAY OF CELLS IN VIVO
HK1203089A1 (zh) 利用 的診斷和風險分層
EP2005168A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSING DISEASES OF AORTA
ZA201001158B (en) Diferentiation of human embryonic stem cells
HK1150839A1 (zh) 用於治療性抗體的組合物及方法
EP2181482A4 (en) DESIGNING A BATTERY ELEMENT AND METHODS FOR ITS CONSTRUCTION
GB0622394D0 (en) Differentiation of pluripotent cells
PL3175853T3 (pl) Przeciwnowotworowe połączenia neratynibu i kapecytabiny
EP2223121A4 (en) METHOD AND KIT FOR USE IN THE DIFFERENTIATION OF IBD AND IBS AND IN COMPLEMENTARY DISTINCTION BETWEEN DIFFERENT TYPES OF IBD DISEASES
EP2298365A4 (en) MEDICAL COMPOSITION AND MEDICAL KIT
EP2069477A4 (en) CHEMOREPULSION OF CELLS
EP2227540A4 (en) DIFFERENTIATION OF HUMAN CELLS
GB0716070D0 (en) Diagnostic method and kit
HK1179168A1 (zh) 治療貧血和紅細胞功能障礙的用途
EP2370414A4 (en) PREPARATION OF CAPECITABINE
EP2330420A4 (en) DIAGNOSTIC METHOD AND DIAGNOSTIC KIT FOR DERMATOMYOSITY
EP2059253A4 (en) MODULATION OF REGULATORY T CELLS BY HUMAN IL-18
GB2476898B (en) VSP imaging of acoustic interfaces
EP2309265A4 (en) METHOD FOR ANALYZING A COMPLEX AND KIT FOR USE THEREFOR
EP1984757A4 (en) EX VIVO HYPER POLARIZATION OF IMAGING AGENTS
EP2334813A4 (en) METHOD AND KITS FOR DIAGNOSIS OF RYR1-DEFICENT DISEASES
HK1157387A1 (en) Use of hsa-producing cells